Cargando…

Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review

Cefiderocol (FDC) is a siderophore cephalosporin now recognized as a new weapon in the treatment of difficult-to-treat-resistant (DTR) Gram-negative pathogens, including carbapenemase-producing enterobacterales and non-fermentative Gram-negative bacilli (GNB). This article reports our experience wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wicky, Paul-Henri, Poiraud, Joséphine, Alves, Manuel, Patrier, Juliette, d’Humières, Camille, Lê, Minh, Kramer, Laura, de Montmollin, Étienne, Massias, Laurent, Armand-Lefèvre, Laurence, Timsit, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295316/ https://www.ncbi.nlm.nih.gov/pubmed/37370310 http://dx.doi.org/10.3390/antibiotics12060991

Ejemplares similares

A Simplified Electroencephalography Montage and Interpretation for Evaluation of Comatose Patients in the ICU
por: Abid, Sonia, et al.
Publicado: (2022)

Augmented renal clearance in the ICU: estimation, incidence, risk factors and consequences—a retrospective observational study
por: Egea, Alexandre, et al.
Publicado: (2022)

Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France
por: d’Humières, Camille, et al.
Publicado: (2021)

Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit
por: Maataoui, Naouale, et al.
Publicado: (2021)

Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS
por: de Montmollin, Etienne, et al.
Publicado: (2022)

Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients
por: Timsit, Jean-François, et al.
Publicado: (2022)

Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults
por: Patrier, Juliette, et al.
Publicado: (2022)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Comparison of Agar Dilution to Broth Microdilution for Testing In Vitro Activity of Cefiderocol against Gram-Negative Bacilli
por: Albano, Mariana, et al.
Publicado: (2020)

In Vivo Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Murine Urinary Tract Infection Models
por: Matsumoto, Shuhei, et al.
Publicado: (2017)

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2020)

Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing
por: Lo, Stéphane, et al.
Publicado: (2022)

648. Cefiderocol as Rescue Therapy for Pseudomonas aeruginosa and Other Difficult-To-Treat Gram-Negative Infections
por: Chou, Andrew, et al.
Publicado: (2022)

Activities of Cefiderocol with Simulated Human Plasma Concentrations against Carbapenem-Resistant Gram-Negative Bacilli in an In Vitro Chemostat Model
por: Matsumoto, Shuhei, et al.
Publicado: (2020)

Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens
por: Thy, Michaël, et al.
Publicado: (2023)

Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome
por: Bouadma, Lila, et al.
Publicado: (2020)

Mechanisms of antimicrobial resistance in Gram-negative bacilli
por: Ruppé, Étienne, et al.
Publicado: (2015)

Gram‐ghost bacilli
por: Kuroda, Hirokazu, et al.
Publicado: (2018)

In-Vitro Efficacy of Cefiderocol in Carbapenem-Non-Susceptible Gram-Negative Bacilli of Different Genotypes in Sub-Region of North Rhine Westphalia, Germany
por: Ghebremedhin, Beniam, et al.
Publicado: (2021)

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
por: Hackel, Meredith A., et al.
Publicado: (2018)

Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics
por: Matsumoto, Shuhei, et al.
Publicado: (2017)

HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients
por: Meyer, Antoine, et al.
Publicado: (2021)

In Vitro Activity of Cefiderocol Compared to Other Antimicrobials against a Collection of Metallo-Beta-Lactamase-Producing Gram-Negative Bacilli from Southern Spain
por: Delgado-Valverde, M., et al.
Publicado: (2023)

In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014–2019
por: Wise, Mark G., et al.
Publicado: (2023)

Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
por: Bavaro, Davide Fiore, et al.
Publicado: (2021)

Natural light exposure and delirium in ICU: does the dark side cloud everything?
por: Sonneville, Romain, et al.
Publicado: (2020)

Acute cor pulmonale in Covid-19 related acute respiratory distress syndrome
por: Cavaleiro, Pedro, et al.
Publicado: (2021)

Analysis of In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Gram-Negative Bacilli by Broth Microdilution and Disk Diffusion Method: A Single-Center Study in Odisha, India
por: Nayak, Gayatree, et al.
Publicado: (2022)

Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
por: Syed, Yahiya Y.
Publicado: (2021)

P35 Heteroresistance to cefiderocol in clinical Gram-negative isolates
por: Watson, Celeste, et al.
Publicado: (2023)

Defining multidrug resistance in Gram-negative bacilli
por: Kumar, V. Anil, et al.
Publicado: (2015)

Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs
por: Dupuis, Claire, et al.
Publicado: (2021)

The role of the microbiota in the management of intensive care patients
por: Szychowiak, Piotr, et al.
Publicado: (2022)

Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
por: Syed, Yahiya Y.
Publicado: (2021)

Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens
por: Pybus, Christine A., et al.
Publicado: (2021)

Performance evaluation of the UMIC(®) Cefiderocol to determine MIC in Gram-negative bacteria
por: Dortet, Laurent, et al.
Publicado: (2023)

The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol
por: Taheri, Yasaman, et al.
Publicado: (2021)

Post-neurosurgical meningitis; gram negative bacilli vs. gram positive cocci
por: Zeinalizadeh, Mehdi, et al.
Publicado: (2022)

Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19
por: Lê, Minh Patrick, et al.
Publicado: (2020)

Colistin in the treatment of infections from multiresistant Gram (-) bacilli
por: Markou, N, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_2tu3lg9gvcmjl2ajrupna17j58